Cargando…

Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy

Cancer drug resistance is an enormous problem. It is responsible for most relapses in cancer patients following apparent remission after successful therapy. Understanding cancer relapse requires an understanding of the processes underlying cancer drug resistance. This article discusses the causes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leary, Meghan, Heerboth, Sarah, Lapinska, Karolina, Sarkar, Sibaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315347/ https://www.ncbi.nlm.nih.gov/pubmed/30518036 http://dx.doi.org/10.3390/cancers10120483

Ejemplares similares

Use of Epigenetic Drugs in Disease: An Overview
por: Heerboth, Sarah, et al.
Publicado: (2014)

Drug Resistance in Cancer: An Overview
por: Housman, Genevieve, et al.
Publicado: (2014)

A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
por: Longacre, Mckenna, et al.
Publicado: (2016)

EMT and tumor metastasis
por: Heerboth, Sarah, et al.
Publicado: (2015)

The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences
por: Willbanks, Amber, et al.
Publicado: (2016)

Brain Tumors: Development, Drug Resistance, and Sensitization – An Epigenetic Approach
por: Sarkar, Sibaji, et al.
Publicado: (2023)

Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs
por: Wojtowicz, Karolina, et al.
Publicado: (2021)

The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro.
por: Bates, D. A., et al.
Publicado: (1990)

Developing Synergistic Drug Combinations To Restore Antibiotic Sensitivity in Drug-Resistant Mycobacterium tuberculosis
por: Omollo, Charles, et al.
Publicado: (2021)

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer
por: Malyutina, Alina, et al.
Publicado: (2019)

Cancer Development, Progression, and Therapy: An Epigenetic Overview
por: Sarkar, Sibaji, et al.
Publicado: (2013)

Understanding Drug Sensitivity and Tackling Resistance in Cancer
por: Tyner, Jeffrey W., et al.
Publicado: (2022)

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
por: Colmegna, B, et al.
Publicado: (2015)

Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
por: Luty, Marcin, et al.
Publicado: (2019)

Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
por: Clarke, Paul A., et al.
Publicado: (2019)

Emergence of prions selectively resistant to combination drug therapy
por: Burke, Cassandra M., et al.
Publicado: (2020)

Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
por: Leary, A, et al.
Publicado: (2006)

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
por: Margue, Christiane, et al.
Publicado: (2019)

Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy
por: Zhang, Wenda, et al.
Publicado: (2017)

Drug Combinations in Breast Cancer Therapy
por: Fisusi, Funmilola A., et al.
Publicado: (2019)

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer
por: Facciotto, Chiara, et al.
Publicado: (2019)

The significance of lumican expression in ovarian cancer drug-resistant cell lines
por: Klejewski, Andrzej, et al.
Publicado: (2017)

Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells
por: Han, Yue, et al.
Publicado: (2019)

Sensitizing drug-resistant cancer cells from blood using microfluidic electroporator
por: Sung, Hyun Woo, et al.
Publicado: (2022)

Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles
por: Zou, Liang, et al.
Publicado: (2017)

Potentiation of Some Anticancer Agents by Dipyridamole against Drug‐sensitive and Drug‐resistant Cancer Cell Lines
por: Asoh, Kuni‐ichi, et al.
Publicado: (1989)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies
por: Joisa, Chinmaya U., et al.
Publicado: (2023)

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
por: Lee, Shannon, et al.
Publicado: (2020)

Drug Resistance and Novel Therapies in Cancers
por: Wang, Zhixiang
Publicado: (2020)

The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen-Resistant Breast Cancer Cells In Vitro
por: Gomaa, Hesham A. M., et al.
Publicado: (2018)

Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells
por: Rezayatmand, Hamed, et al.
Publicado: (2022)

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
por: Roberts, D, et al.
Publicado: (2005)

Dynamic vs Static ABCG2 Inhibitors to Sensitize Drug Resistant Cancer Cells
por: Peng, Hui, et al.
Publicado: (2010)

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
por: Chin, Tan-Min, et al.
Publicado: (2020)

Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies
por: Wenzel, Mike, et al.
Publicado: (2021)

Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
por: Januchowski, Radosław, et al.
Publicado: (2016)

Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
por: Meng, Jie, et al.
Publicado: (2016)

Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
por: Nsanzabana, Christian
Publicado: (2019)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_le220q7pm7a1inolmj2eb89kir